What they were paid
C4 Therapeutics Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $79,500 | $0 | $39,749 | $0 | $119,249 |
| FY2024 | $43,299 | — | $302,900 | — | $346,199 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: C4 Therapeutics, Inc. DEF 14A filed April 29, 2026, accession 0001628280-26-028104, and prior-year filings. Open the filing on EDGAR.
Committees
FY2025 · as the proxy prints themNominating/Governance (Chair)
The rest of the C4 Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Andrew J. Hirsch | Director | $0 |
| Donna Grogan | Independent Director | $96,999 |
| Kenneth C. Anderson | Independent Director | $85,499 |
| Laura Bessen | Independent Director | $90,249 |
| Owen P. Hughes Jr | Independent Director | $89,958 |
| Stephen Fawell | Independent Director | $85,499 |
| Stephen Hoerter | Independent Director | $90,312 |
| Utpal Koppikar | Independent Director | $100,499 |
The full C4 Therapeutics compensation record
free company briefThis page is one director within C4 Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat